Position in TAK
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$4,055,454
+$692,271 QoQ
Shares Held
218,977
+1.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 98.42175205615202.ToString("F0")%
Shared 0.ToString("F0")%
None 1.5782479438479842.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MANNING & NAPIER ADVISORS LLC holds $24,582,865 across 6 Drug Manufacturers - Specialty & Generic names. TAK ranks #2 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,280,796 | $17,303,553 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
218,977 | $4,055,454 | |
| 3 | HLN |
Haleon plc
|
306,509 | $3,068,155 | |
| 4 | ZTS |
Zoetis Inc.
|
1,304 | $154,145 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
43 | $1,295 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
2 | $263 |
All Filings in TAK
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,055,454 | 218,977 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,363,183 | 215,727 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,315,052 | 226,438 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,791,425 | 245,241 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,424,167 | 297,523 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $4,030,481 | 304,417 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,521,121 | 317,941 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $4,097,968 | 316,690 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||